Mechanisms involved in the differential bone marrow homing of CD45 subsets in 5T murine models of myeloma
暂无分享,去创建一个
K. Vanderkerken | E. Van Valckenborgh | E. Menu | I. Vande broek | B. Van Camp | K. Asosingh | I. Van Riet
[1] D. Eizirik,et al. Monocyte chemoattractant protein-1 (MCP-1), secreted by bone marrow endothelial cells, induces chemoattraction of 5T multiple myeloma cells , 2004, Clinical & Experimental Metastasis.
[2] L. Devy,et al. Murine 5T multiple myeloma cells induce angiogenesis in vitro and in vivo , 2002, British Journal of Cancer.
[3] K. Vanderkerken,et al. Laminin-1-induced migration of multiple myeloma cells involves the high-affinity 67 kD laminin receptor , 2001, British Journal of Cancer.
[4] K. Vanderkerken,et al. A unique pathway in the homing of murine multiple myeloma cells: CD44v10 mediates binding to bone marrow endothelium. , 2001, Cancer research.
[5] Susan Biggin,et al. Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin‐3‐gallate , 2001, Cancer.
[6] P. Croucher,et al. In vivo homing and differentiation characteristics of mature (CD45-) and immature (CD45+) 5T multiple myeloma cells. , 2001, Experimental hematology.
[7] K. Vanderkerken,et al. In vivo induction of insulin-like growth factor-I receptor and CD44v6 confers homing and adhesion to murine multiple myeloma cells. , 2000, Cancer research.
[8] J. Woodliff,et al. Expression of urokinase plasminogen activator and the urokinase plasminogen activator receptor in myeloma cells , 2000, British journal of haematology.
[9] H. Gårdsvoll,et al. Generation of high-affinity rabbit polyclonal antibodies to the murine urokinase receptor using DNA immunization. , 2000, Journal of immunological methods.
[10] B. Smedsrød,et al. Selective initial in vivo homing pattern of 5T2 multiple myeloma cells in the C57BL/KalwRij mouse , 2000, British Journal of Cancer.
[11] J. Foidart,et al. Bone marrow microenvironmental-induced upregulation of MMP-9 activity in murine multiple myeloma cells , 2000 .
[12] K. Vanderkerken,et al. Monocyte chemoattractant-1 (MCP-1), secreted by bone marrow endothelial cells, induces chemoattraction of multiple myeloma cells. , 2000 .
[13] K. Vanderkerken,et al. The 5TMM series: a useful in vivo mouse model of human multiple myeloma. , 2000, The hematology journal : the official journal of the European Haematology Association.
[14] R. Bataille,et al. Production of metalloproteinase-7 (matrilysin) by human myeloma cells and its potential involvement in metalloproteinase-2 activation. , 1999, Journal of immunology.
[15] M. Dhodapkar,et al. Syndecan-1 (CD 138) in myeloma and lymphoid malignancies: a multifunctional regulator of cell behavior within the tumor microenvironment. , 1999, Leukemia & lymphoma.
[16] G. Kaushal,et al. Syndecan‐1 expression suppresses the level of myeloma matrix metalloproteinase‐9 , 1999, British journal of haematology.
[17] F. Braet,et al. Insulin-like growth factor-1 acts as a chemoattractant factor for 5T2 multiple myeloma cells. , 1999, Blood.
[18] D. Ribatti,et al. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. , 1999, Blood.
[19] F. Blasi,et al. Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes , 1997, The EMBO journal.
[20] L. Devy,et al. Emerging roles for proteinases in cancer. , 1997, Invasion & metastasis.
[21] K. Thielemans,et al. Organ involvement and phenotypic adhesion profile of 5T2 and 5T33 myeloma cells in the C57BL/KaLwRij mouse. , 1997, British Journal of Cancer.
[22] L. Picker,et al. Lymphocyte Homing and Homeostasis , 1996, Science.
[23] R. Muschel,et al. Metalloproteinases in tumor progression: the contribution of MMP-9. , 1994, Invasion & metastasis.
[24] L. Liotta,et al. Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[25] S. Poppema,et al. Transition in CD45 isoform expression during differentiation of normal and abnormal B cells. , 1989, International immunology.
[26] J. Croese,et al. Animal model of human disease. Multiple myeloma. , 1988, The American journal of pathology.
[27] H. Strander. Interferon treatment of human neoplasia. , 1986, Advances in cancer research.
[28] L. Liotta. Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture. , 1986, Cancer research.
[29] L. Liotta,et al. Metastatic potential correlates with enzymatic degradation of basement membrane collagen , 1980, Nature.
[30] J. Radl,et al. Idiopathic paraproteinemia. II. Transplantation of the paraprotein-producing clone from old to young C57BL/KaLwRij mice. , 1979, Journal of immunology.
[31] R. Vracko,et al. Basal lamina scaffold-anatomy and significance for maintenance of orderly tissue structure. , 1974, The American journal of pathology.